HOME >> MEDICINE >> NEWS
Safe And Effective Treatment For Acute Repetitive Seizures

A unique gel formulation of diazepam safely reduces the severity of acute repetitive seizure episodes in both children and adults, according to a study published in the June 25, 1998, issue of The New England Journal of Medicine* and funded by the National Institute of Neurological Disorders and Stroke (NINDS). Acute repetitive seizures are episodes of multiple seizures that differ from the individual's usual seizure pattern and are often distinctly recognizable by the patient's family and caregivers. The repetitive seizures may occur serially or in clusters and may last minutes to hours. Acute repetitive seizures may require emergency treatment, especially if they progress to status epilepticus, a potentially fatal condition in which a seizure is sustained.

Seizures occur as a result of abnormal electrical activity in the brain. Epilepsy, a common neurological disorder marked by repeated seizures, affects more than 2 million Americans. Benzodiazepines, a class of drugs that includes diazepam and lorazepam, are generally agreed to be the treatment of choice for acute repetitive seizures.

"This new method of treatment clearly reduces the number of seizures for both children and adults and protects patients from seizure recurrence," said Philip H. Sheridan, M.D., Chief of the NINDS Epilepsy Branch. "Informed caregivers are often able to recognize the onset of a seizure cluster. Now, with this preparation, they can be trained to administer treatment privately, quickly, and safely."

The study was a randomized, double-blind study of 91 individuals with acute repetitive seizures. It was conducted by investigators collaborating at ten university medical centers nationwide. The NINDS provided support to six of the 10 centers participating in the Rectal Administration of Diazepam for Acute Repetitive Seizures (RADARS) study. A frequently reported side effect was sleepiness, common to most medicines used to treat epilepsy.

The new preparation is ma
'"/>

Contact: Stephanie Clipper
301/496-5751
NIH/National Institute of Neurological Disorders and Stroke
24-Jun-1998


Page: 1 2

Related medicine news :

1. HIV-1 protease inhibitors: Effective against malaria?
2. Effectiveness of safer smallpox vaccine demonstrated against monkeypox
3. Effectiveness of chickenpox vaccine decreases after one year
4. Effective treatment for diabetes depends on the underlying cause
5. Effectiveness of drugs used to treat Parkinsons disease in early, later stages measured
6. Effective treatment for children with ADHD and chronic tic disorders
7. Effective Clinical Practice, Jan/Feb. 2002 Highlights
8. Effective surgery fails to attract patients unless costs are low
9. Effective Clinical Practice, Nov/Dec 2000 highlights
10. Effective Clinical Practice, Sept/Oct 2000 highlights
11. Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Safe And Effective Treatment For Acute Repetitive Seizures

(Date:5/23/2013)... San Francisco, CA (PRWEB) May 23, 2013 ... community safety outreach program being tackled by the Safe ... its second Fullpower personal safety workshop for ... develops and teaches personal safety skills programs for people ... been telling us their experiences with street harassment for ...
(Date:5/23/2013)... Lake City, Utah (PRWEB) May 23, 2013 ... Chevreau, PhD, R.D., published an article today on Tatalou.com ... an illness-free vacation. , The article, titled “ How ... why it’s important to carry hand sanitizer, when it’s ... to watch out for seafood, the importance of staying ...
(Date:5/23/2013)... 23, 2013 Dimensional Insight, a ... announced today that Paul Comras, director of ... at the 2013 International Medical Users Software Exchange ... & Revenue Visibility from Your General Ledger.” The ... from 2:30-3:25 p.m. in Azalea 1 at the ...
(Date:5/23/2013)... Alexandria, VA (PRWEB) May 23, 2013 Memorial ... start of the summer season for many Americans. Across the ... the long weekend. NHPCO encourages Americans to reach out to ... in military service. , As the nation marks Memorial Day ... Serious injuries and the untimely deaths of brave service men ...
(Date:5/23/2013)... To better serve the architecture ... pleased to announce the release of its new ... space division products. Provided by Koroseal, a leader ... patterns and colors represent a sophisticated response to ... a team of Koroseal experts, Modernfold reviewed hundreds ...
Breaking Medicine News(10 mins):Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 2Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 3Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 4Health News:How to Stay Healthy While Traveling 2Health News:Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference 2Health News:Memorial Day: Make it a Time of Remembrance and Support 2Health News:Memorial Day: Make it a Time of Remembrance and Support 3Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2
(Date:5/23/2013)... 2013  Inhibikase Therapeutics, Inc., an emerging leader ... will present new results on its antiviral program ... by the PML Consortium (composed of Pfizer, Bristol-Meyers ... is the causative agent of Progressive Multifocal Leukoencephalopathy ... an extended release formulation, can clear JC polyomavirus ...
(Date:5/23/2013)... 23, 2013  Echo Pharma Acquisition Limited ("Royalty Pharma") ... the Acceptance Threshold from 90 percent to 50 percent ... in accordance with the terms of the Revised Offer ... Under the terms of the Increased Offer, ... ELN ) for $12.50 per share in cash. ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
Cached News: